MedMira Financials
| MMIRF Stock | USD 0.08 0.01 8.04% |
MedMira |
MedMira Stock Summary
MedMira competes with Pharming Group. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America, the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. Medmira operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | CA58501R1029 |
| Business Address | 155 Chain Lake |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medmira.com |
| Phone | 902 450 1588 |
| Currency | USD - US Dollar |
MedMira Key Financial Ratios
There are many critical financial ratios that MedMira's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MedMira reports annually and quarterly.MedMira Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MedMira's current stock value. Our valuation model uses many indicators to compare MedMira value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedMira competition to find correlations between indicators driving MedMira's intrinsic value. More Info.MedMira is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedMira's earnings, one of the primary drivers of an investment's value.MedMira Systematic Risk
MedMira's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MedMira volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on MedMira correlated with the market. If Beta is less than 0 MedMira generally moves in the opposite direction as compared to the market. If MedMira Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MedMira is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MedMira is generally in the same direction as the market. If Beta > 1 MedMira moves generally in the same direction as, but more than the movement of the benchmark.
MedMira February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MedMira help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MedMira. We use our internally-developed statistical techniques to arrive at the intrinsic value of MedMira based on widely used predictive technical indicators. In general, we focus on analyzing MedMira Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MedMira's daily price indicators and compare them against related drivers.
| Information Ratio | 0.104 | |||
| Maximum Drawdown | 498.47 |
Complementary Tools for MedMira Pink Sheet analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |